Pharmacom Biovet Stock Today
PHMB Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 88
|
Pharmacom Biovet is trading at 1.0E-4 as of the 26th of January 2025, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Pharmacom Biovet has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 6th of February 2023 and ending today, the 26th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina. PHARMACOM BIOVET operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.. More on Pharmacom Biovet
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pharmacom Stock Highlights
Pharmacom Biovet (PHMB) is traded on OTCCE Exchange in USA and employs 3 people. Pharmacom Biovet is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.08 M. Pharmacom Biovet conducts business under Health Care Providers & Services sector and is part of Health Care industry.
Check Pharmacom Biovet Probability Of Bankruptcy
Pharmacom Stock Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmacom Biovet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. If investors know Pharmacom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmacom Biovet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmacom Biovet is measured differently than its book value, which is the value of Pharmacom that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmacom Biovet's value that differs from its market value or its book value, called intrinsic value, which is Pharmacom Biovet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmacom Biovet's market value can be influenced by many factors that don't directly affect Pharmacom Biovet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmacom Biovet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmacom Biovet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.